Acuitas Investments’s BioLife Solutions BLFS Stock Holding History

Acuitas Investments’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-104,002	Closed	-$2.37M	–	42
2022 Q3	$2.37M	Hold	104,002	–	–	2.45%	15
2022 Q2	$1.44M	Buy	+104,002	New	+$1.53M	1.39%	32
2022 Q1	–	Sell	-25,495	Closed	-$950K	–	35
2021 Q4	$950K	Sell	25,495 -208	-0.8%	-$8.93K	0.4%	61
2021 Q3	$1.09M	Sell	25,703 -8,185	-24%	-$394K	0.48%	66
2021 Q2	$1.51M	Sell	33,888 -1,030	-3%	-$36.3K	0.75%	58
2021 Q1	$1.26M	Sell	34,918 -20,770	-37%	-$821K	0.72%	60
2020 Q4	$2.22M	Sell	55,688 -47,878	-46%	-$1.63M	1.44%	32
2020 Q3	$3M	Sell	103,566 -1,211	-1%	-$26.2K	2.1%	15
2020 Q2	$1.71M	Buy	+104,777	New	+$1.44M	2.15%	23

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Acuitas Investments's BLFS Position: Q4 2022 in Review

Acuitas Investments sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 104,002 shares — an estimated $2.37M sold.

Acuitas Investments first reported a position in BLFS in Q2 2020 and held it in 9 quarters. The position peaked at $3M in Q3 2020. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

Acuitas Investments reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
Acuitas Investments sold 104,002 BioLife Solutions shares in Q4 2022, an estimated $2.37M.
Acuitas Investments first reported a position in BioLife Solutions in Q2 2020 and held it in 9 quarters.
Acuitas Investments's BioLife Solutions position peaked at $3M in Q3 2020.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Acuitas Investments's 13F filing for Q4 2022, filed 6 Feb 2023.